Detection of soluble alloantigen immune complexes

Plastic article or earthenware shaping or treating: apparatus – Means making particulate material directly from liquid or... – By means applying fluid jet or blast to unconfined liquid...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 794, 436507, 436518, 436539, G01N 33539, G01N 33543, G01N 33564

Patent

active

052565416

ABSTRACT:
Reactivity between alloantigen and alloantigen-specific ligand, such as HLA and anti-HLA antibody, is detectable in a sample by separating from the sample a portion of a targeted class of ligands (including such ligands complexed with alloantigen) and measuring the amount of alloantigen in such complex containing fractions. In another embodiment of the invention, reactivity between a plurality of samples is detected by measuring soluble alloantigen in at least first and second biological samples and in a mixture of the samples. Since the formation of alloantigen immune-complexes in the mixture alters the physical and immunological behavior of soluble alloantigen, a divergence between the measured and expected concentration of the mixture indicates reactivity.

REFERENCES:
patent: 4681782 (1987-07-01), Ozkan
patent: 4810632 (1989-03-01), McMillan
Y. Iwaki, et al., (1988) Clinical Transplantation 2:81-84. Successful transplants across T warm-positive crossmatches due to IgM antibodies.
Grosse-Wilde and Doxiadis (1989) J. Immunogenetics 16:149-155. Allotyping for HLA Class I using plasma as antigen source.
F. Stevenson, et al. (1986) J. Imm. Methods 86:187-190. Analysis of soluble HLA Class II antigenic material in patients with immunological disease using monoclonal antibodies.
D. Talbot, et al. (1988) J. Imm. Methods 112:279-283. Rapid detection of low levels of donor specific IgG by flow cytometry with single and dual colour fluorescence in renal transplantation.
R. Duquesnoy, et al. (1990) Transplantation 50:427-437. Multiscreen serum analysis of highly sensitized renal dialysis patients of antibodies toward public and private Class I HLA determinants.
S. Martin, et al. (1987) Transplantation 50:427-437. Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome.
R. Tsuji, et al., (1985) Tokai J. Exp. Clin. Med. 10:169-174. Biological significance of Ss (serum soluble) HLA-Class I antigens in bone marrow transplantation.
R. Fauchet, et al., (1989) Transplantaiton 30:114-129. Occurance and specificity of anti-B lymphocyte antibodies in renal allograft recipients.
H. Davies, et al. (1989) Transplantation 47:524-527. Soluble HLA antigens in the circulation of liver graft recipients.
Doxiadis and Grosse-Wide (1989) Vox Sang 56:196-199. Typing for HLA Class I gene products using plasma as source.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Detection of soluble alloantigen immune complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection of soluble alloantigen immune complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of soluble alloantigen immune complexes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-958588

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.